Molecular target drugs are medications designed to interact with specific molecular targets in the patient’s body.
In certain types of cancer, recent studies have allowed a better understanding of some mechanisms involved in the development and progression of the disease. These mechanisms often involve the altered function of some proteins found on the surface or inside tumor cells.
These proteins have become targets for the development of cancer-fighting drugs. These new medications are called molecular target drugs.
Among the molecular target drugs used in cancer treatment are tyrosine kinase inhibitors and monoclonal antibodies.
Molecular target drugs have been used in molecular target therapy either alone or in combination with chemotherapy. To learn more about molecular target drugs, please refer to the Frequently Asked Questions section – Molecular Target Drugs.
